+44 1300 500008Journal of Leukemia : Citations & Metrics Report
Articles published in Journal of Leukemia have been cited by esteemed scholars and scientists all around the world. Journal of Leukemia has got h-index 11, which means every article in Journal of Leukemia has got 11 average citations.
Following are the list of articles that have cited the articles published in Journal of Leukemia.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|
Year wise published articles |
62 | 23 | 11 | 8 | 22 | 23 |
Year wise citations received |
54 | 59 | 64 | 98 | 109 | 74 |
| Journal total citations count | 618 |
| Journal impact factor | 2.11 |
| Journal 5 years impact factor | 3.71 |
| Journal cite score | 3.91 |
| Journal h-index | 11 |
| Journal h-index since 2018 | 8 |
Important citations (462)
gv rr. types of cancer and surgery in rats (rattus norvegicus). growth.;91:95. |
|
nigm da, abd el hameed za, abd elrahman mz. cd30 expressiona vs. serum soluble cd30 (scd30) level: role in prognosis and treatment of acute myeloid leukaemia. j clin cell immunol. 2017;8(510):2. |
|
Gv rr. types of cancer and surgery in rats (rattus norvegicus). growth.;91:95. |
|
latif es, basri df, nagapan ts. toxicological effect of canarium odontophyllum extract against acute lymphoblastic leukemia ccl-119 cell line. |
|
adamczyk k, olech m, abramek j, pietrzak w, kuåºniewski r, bogucka-kocka a, et al. eleutherococcus species cultivated in europe: a new source of compounds with antiacetylcholinesterase, antihyaluronidase, anti-dpph, and cytotoxic activities. oxid med cell longev. 2019. |
|
lajnef l, caceres i, trinsoutrot p, charrier-el bouhtoury f, ayed n, charrier b. effect of punica granatum peel and melia azedarach bark extracts on durability of european beech and maritime pine. eur j wood wood prod. 2018;76(6): 1725-1735. |
|
Tóth z, lukács g, cselik z, bajzik g, egyed m, vajda z, et al. a pet/mr képalkotás magyarországi klinikai alkalmazásának lehetÅÃ?â??ségei, elsÅÃ?â?? tapasztalatai. orvosi hetilap. 2018;159(34): 1375-1384. |
|
Lee hr, baek kh. role of natural killer cells for immunotherapy in chronic myeloid leukemia. oncol rep. 2019;41(5): 2625-2635. |
|
Leick mb, maus mv. car-t cells beyond cd19, uncar-ted territory. american j hematol. 2019;94(s1): s34-s41. |
|
Beyar-katz o, gill s. novel approaches to acute myeloid leukemia immunotherapy. clin cancer res. 2018;24(22): 5502-5515. |
|
Rubio sg, lancheros a, yusselfy mÃ, heredia mm, barros jo. caracterización biológica del marcador cd66c y su importancia clÃnica en la leucemia linfoide aguda. revista cubana de hematologÃa, inmunologÃa y hemoterapia. 2018;34(3). |
|
cruz rubio s, lancheros a, márquez benitez y, mosquera heredia m, oliveros barros j. caracterización biológica del marcador cd66c y su importancia clínica en la leucemia linfoide aguda. revista cubana de hematología, inmunología y hemoterapia. 2018;34(3): 1-2. |
|
Cruz rubio s, lancheros a, márquez benitez y, mosquera heredia m, oliveros barros j. biological characterization of the cd66c marker and its clinical importance in acute lymphoid leukemia. revista cubana de hematología, inmunología y hemoterapia. 2018;34(3): 1-2. |
|
Incidentally detected non-hodgkin's lymphoma of the breast. a case report with review of literature |
|
jakó j, szerafin l. malignus hematológiai kórképek társulása. hematológia–transzfuziológia. 2019; 52(1): 30-36. |
|
조벼리. genomic and transcriptomic landscape of two-step malignant transformation in x-irradiated c3h10t1/2 cells (doctoral dissertation, ìâ??Å?울ëÅ?â?¬Ãâ?¢â?¢ÃªÂµÂ ëÅ?â?¬Ãâ?¢â?¢Ã¬â?ºÂ). |
|
Bertino j, sabaawy he, kim i. therapeutic role of bmi-1 inhibitors in eliminating prostate tumor stem cells. rutgers-the state univ new brunswick nj; 2015 oct. |
|
Arbesman j, inventor; university hospitals of cleveland, assignee. anti-metastasis treatment of melanoma. united states patent application us 15/391,516. 2017 jun 29. |
|
Zhang z, zhang w. fragmentation patterns of circulating cell-free dna demonstrate biomarker potential for human cancers. biotarget. 2019 aug;3. |
|
Bray lj, hutmacher dw, bock n. addressing patient specificity in the engineering of tumor models. frontiers in bioengineering and biotechnology. 2019;7:217. |
|